Reduced intake impacts gut health, energy metabolism, and cognitive clarity alongside bone strength
Diabetes Care (2015) 38(12):22419
Gastroenterology 134:11371147 Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR (2002) Guthormone PYY(336) physiologically inhibits food intake
Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes2025
On the other hand, a BMI below 27 without additional health problems does not qualify them to receive a prescription
Risk-benefit implications With increasing prevalence of GLP-1 agonists in our perioperative population and emerging reports of retained gastric content despite recommended fasting guidelines, a review on the perioperative handling of GLP-1 agonists and assessment of these patients are warranted to balance their cardiometabolic benefits and unquantified risk of catastrophic pulmonary aspiration